Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Sedegah, Martha ^a   Kim, Yohan ^b   Ganeshan, Harini ^a   Huang, Jun ^a   Belmonte, Maria ^a   Abot, Esteban ^a   Banania, Jo Glenna ^a   Farooq, Fouzia ^a   McGrath, Shannon ^a   Peters, Bjoern ^b   Sette, Alessandro ^b   Soisson, Lorraine ^d   Diggs, Carter ^d   Doolan, Denise L ^c   Tamminga, Cindy ^a   Villasante, Eileen ^a   Hollingdale, Michael R ^a   Richie, Thomas L ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

Author keywords

Circumsporozoite protein; Class I restriction; ELISpot; Epitope mapping; Flow cytometry; Localization; Malaria; NetMHC; Vaccine

Indexed keywords

ADENOVIRUS VECTOR; CIRCUMSPOROZOITE PROTEIN; HLA A ANTIGEN;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HLA MATCHING; HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM FALCIPARUM;

CLINICAL TRIALS AS TOPIC; COMPUTATIONAL BIOLOGY; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMAN EXPERIMENTATION; HUMANS; MALARIA VACCINES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 84878434288     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-185     Document Type: Article

References (62)

1. Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. Moorthy VS, Ballou WR, Malar J 2009 8 312 10.1186/1475-2875-8-312 20042088
2. Protective immunity induced with malaria vaccine, RTS, S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma. Sun P, Schwenk R, White K, Stoute JA, Cohen J, Ballou WR, Voss G, Kester KE, Heppner DG, Krzych U, J Immunol 2003 171 6961 6967 14662904
3. CD8+ T effector memory cells protect against liver-stage malaria. Reyes-Sandoval A, Wyllie DH, Bauza K, Milicic A, Forbes EK, Rollier CS, Hill AV, J Immunol 2011 187 1347 1357 10.4049/jimmunol.1100302 21715686
4. The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. Coppi A, Natarajan R, Pradel G, Bennett BL, James ER, Roggero MA, Corradin G, Persson C, Tewari R, Sinnis P, J Exp Med 2011 208 341 356 10.1084/jem.20101488 21262960
5. Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro. Bongfen SE, Torgler R, Romero JF, Renia L, Corradin G, J Immunol 2007 178 7054 7063 17513754
6. Viral vectors in malaria vaccine development. Limbach KJ, Richie TL, Parasite Immunol 2009 31 501 519 10.1111/j.1365-3024.2009.01141.x 19691555
7. Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part a: safety and immunogenicity in seronegative adults. Sedegah M, Tamminga C, McGrath S, House B, Ganeshan H, Lejano J, Abot E, Banania G, Sayo R, Farooq F, Belmonte M, Manohar N, Richie NO, Wood C, Long CA, Regis D, Williams FT, Shi M, Chuang I, Spring M, Epstein JE, Mendoza-Silveiras J, Limbach K, Patterson NB, Bruder JT, Doolan DL, King CR, Soisson L, Diggs C, Carucci D, Dutta S, Hollingdale MR, Ockenhouse CF, Richie TL, PLoS One 2011 6 24586 10.1371/journal.pone.0024586 22003383
8. Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: Safety, immunogenicity and protective efficacy of the CSP component. Tamminga C, Sedegah M, Regis D, Chuang I, Epstein JE, Spring M, Mendoza-Silveiras J, McGrath S, Maiolatesi S, Reyes S, Steinbeiss V, Fedders C, Smith K, House B, Ganeshan H, Lejano J, Abot E, Banania GJ, Sayo R, Farooq F, Belmonte M, Murphy J, Komisar J, Williams J, Shi M, Brambilla D, Manohar N, Richie NO, Wood C, Limbach K, Patterson NB, Bruder JT, Doolan DL, King CR, Diggs C, Soisson L, Carucci D, Levine G, Dutta S, Hollingdale MR, Ockenhouse CF, Richie TL, PLoS One 2011 6 25868 10.1371/journal.pone.0025868 22003411
9. Human adenovirus 5-vectored plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well tolerated and immunogenic but does not protect against controlled human malaria infection. Tamminga C, Sedegah M, Maiolatesi S, Fedders C, Reyes S, Reyes A, Vasquez C, Alcorta Y, Chuang I, Spring M, et al. Hum Vaccin Immunother 2013 In press
10. Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, Huang Y, Spies GA, De Rosa SC, McElrath MJ, J Clin Invest 2012 122 359 367 10.1172/JCI60202 22201684
11. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. Silvie O, Franetich JF, Charrin S, Mueller MS, Siau A, Bodescot M, Rubinstein E, Hannoun L, Charoenvit Y, Kocken CH, Thomas AW, Van Gemert GJ, Sauerwein RW, Blackman MJ, Anders RF, Pluschke G, Mazier D, J Biol Chem 2004 279 9490 9496 10.1074/jbc.M311331200 14676185
12. DNA prime/adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, Patterson N, Guerrero M, Bennett JW, McGrath MG, Ganeshan H, Belmonte M, Farooq F, Abot E, Banania JG, Huang J, Newcomer R, Rein L, Litilit D, Richie NO, Wood C, Murphy J, Sauerwein R, Hermsen CC, McCoy AJ, Kamau E, Cummings J, Komisar J, Sutamihardja A, Shi M, Epstein JE, Maiolatesi S, Tosh D, Limbach K, Angov E, Bergmann-Leitner E, Bruder JT, Doolan DL, King CR, Carucci D, Dutta S, Soisson L, Diggs C, Hollingdale MR, Ockenhouse CF, Richie TL, PLoS One 2013 8 55571 10.1371/journal.pone.0055571 23457473
13. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, Buus S, Brunak S, Lund O, Protein Sci 2003 12 1007 1017 10.1110/ps.0239403 12717023
14. Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein. Sedegah M, Kim Y, Peters B, McGrath S, Ganeshan H, Lejano J, Abot E, Banania G, Belmonte M, Sayo R, Farooq F, Doolan DL, Regis D, Tamminga C, Chuang I, Bruder JT, King CR, Ockenhouse CF, Faber B, Remarque E, Hollingdale MR, Richie TL, Sette A, Malar J 2011 9 241
15. Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. Plassmeyer ML, Reiter K, Shimp RL Jr, Kotova S, Smith PD, Hurt DE, House B, Zou X, Zhang Y, Hickman M, Uchime O, Herrera R, Nguyen V, Glen J, Lebowitz J, Jin AJ, Miller LH, MacDonald NJ, Wu Y, Narum DL, J Biol Chem 2009 284 26951 26963 10.1074/jbc.M109.013706 19633296
16. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS, S malaria vaccine. Zeeshan M, Alam MT, Vinayak S, Bora H, Tyagi RK, Alam MS, Choudhary V, Mittra P, Lumb V, Bharti PK, Udhayakumar V, Singh N, Jain V, Singh PP, Sharma YD, PLoS One 2012 7 43430 10.1371/journal.pone.0043430 22912873
17. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against plasmodium falciparum malaria. RTS, S malaria vaccine evaluation group. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garcon N, Krzych U, Marchand M, N Engl J Med 1997 336 86 91 10.1056/NEJM199701093360202 8988885
18. Towards an RTS, S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter reed army institute of research. Heppner DG Jr, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garçon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J, Vaccine 2005 23 2243 2250 10.1016/j.vaccine.2005.01.142 15755604
19. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Good MF, Pombo D, Quakyi IA, Riley EM, Houghten RA, Menon A, Alling DW, Berzofsky JA, Miller LH, Proc Natl Acad Sci USA 1988 85 1199 1203 10.1073/pnas.85.4.1199 2448793
20. Major population differences in T cell response to a malaria sporozoite vaccine candidate. Zevering Y, Houghten RA, Frazer IH, Good MF, Int Immunol 1990 2 945 955 10.1093/intimm/2.10.945 1706620
21. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. Doolan DL, Southwood S, Chesnut R, Appella E, Gomez E, Richards A, Higashimoto YI, Maewal A, Sidney J, Gramzinski RA, Mason C, Koech D, Hoffman SL, Sette A, J Immunol 2000 165 1123 1137 10878392
22. Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. Lockyer MJ, Marsh K, Newbold CI, Mol Biochem Parasitol 1989 37 275 280 10.1016/0166-6851(89)90159-X 2481827
23. Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein. Sinigaglia F, Guttinger M, Gillessen D, Doran DM, Takacs B, Matile H, Trzeciak A, Pink JR, Eur J Immunol 1988 18 633 636 10.1002/eji.1830180422 2452748
24. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Doolan DL, Hoffman SL, Southwood S, Wentworth PA, Sidney J, Chesnut RW, Keogh E, Appella E, Nutman TB, Lal AA, Gordon DM, Oloo A, Sette A, Immunity 1997 7 97 112 10.1016/S1074-7613(00)80513-0 9252123
25. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y, Jones TR, Hobart P, Margalith M, Ng J, Weiss WR, Sedegah M, de Taisne C, Norman JA, Hoffman SL, Science 1998 282 476 480 9774275
26. Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. Blum-Tirouvanziam U, Servis C, Habluetzel A, Valmori D, Men Y, Esposito F, Del Nero L, Holmes N, Fasel N, Corradin G, J Immunol 1995 154 3922 3931 7535817
27. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Aidoo M, Lalvani A, Allsopp CE, Plebanski M, Meisner SJ, Krausa P, Browning M, Morris-Jones S, Gotch F, Fidock DA, Druilhe P, Takiguchi M, Lancet 1995 345 1003 1007 10.1016/S0140-6736(95) 90754-8 7536870
28. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Hill AV, Elvin J, Willis AC, Aidoo M, Allsopp CE, Gotch FM, Gao XM, Takiguchi M, Greenwood BM, Townsend AR, McMichael AJ, Whittle HC, Nature 1992 360 434 439 10.1038/360434a0 1280333
29. A protein particle vaccine containing multiple malaria epitopes. Gilbert SC, Plebanski M, Harris SJ, Allsopp CE, Thomas R, Layton GT, Hill AV, Nat Biotechnol 1997 15 1280 1284 10.1038/nbt1197-1280 9359112
30. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Dodoo D, Hollingdale MR, Anum D, Koram KA, Gyan B, Akanmori BD, Ocran J, Adu-Amankwah S, Geneshan H, Abot E, Legano J, Banania G, Sayo R, Brambilla D, Kumar S, Doolan DL, Rogers WO, Epstein J, Richie TL, Sedegah M, Malar J 2011 10 168 10.1186/1475-2875-10-168 21689436
31. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Sette A, Sidney J, Immunogenetics 1999 50 201 212 10.1007/s002510050594 10602880
32. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Sette A, Sidney J, Curr Opin Immunol 1998 10 478 482 10.1016/S0952-7915(98)80124-6 9722926
33. HLA class I supertypes: a revised and updated classification. Sidney J, Peters B, Frahm N, Brander C, Sette A, BMC Immunol 2008 9 1 10.1186/1471-2172-9- 1 18211710
34. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, Sidney J, del Guercio MF, Southwood S, Kubo RT, Chesnut RW, Grey HM, Chisari FV, J Immunol 1994 153 5586 5592 7527444
35. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Doolan DL, Southwood S, Freilich DA, Sidney J, Graber NL, Shatney L, Bebris L, Florens L, Dobano C, Witney AA, Appella E, Hoffman SL, Yates JR 3rd, Carucci DJ, Sette A, Proc Natl Acad Sci USA 2003 100 9952 9957 10.1073/pnas.1633254100 12886016
36. The immune epitope database 2.0. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B, Nucleic Acids Res 2013 38 Database issue 854 862
37. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A, Eur J Immunol 1989 19 2237 2242 10.1002/eji.1830191209 2481588
38. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. Frahm N, Korber BT, Adams CM, Szinger JJ, Draenert R, Addo MM, Feeney ME, Yusim K, Sango K, Brown NV, SenGupta D, Piechocka-Trocha A, Simonis T, Marincola FM, Wurcel AG, Stone DR, Russell CJ, Adolf P, Cohen D, Roach T, StJohn A, Khatri A, Davis K, Mullins J, Goulder PJ, Walker BD, Brander C, J Virol 2004 78 2187 2200 10.1128/JVI.78.5.2187-2200.2004 14963115
39. Extensive HLA class I allele promiscuity among viral CTL epitopes. Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J, Hraber P, Hewitt HS, Linde CH, Kavanagh DG, Woodberry T, Henry LM, Faircloth K, Listgarten J, Kadie C, Jojic N, Sango K, Brown NV, Pae E, Zaman MT, Bihl F, Khatri A, John M, Mallal S, Marincola FM, Walker BD, Sette A, Heckerman D, Korber BT, Brander C, Eur J Immunol 2007 37 2419 2433 10.1002/eji.200737365 17705138
40. HLA class I allele promiscuity revisited. Rao X, Hoof I, Costa AI, van Baarle D, Kesmir C, Immunogenetics 2011 63 691 701 10.1007/s00251-011-0552-6 21695550
41. Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Wang R, Epstein J, Baraceros FM, Gorak EJ, Charoenvit Y, Carucci DJ, Hedstrom RC, Rahardjo N, Gay T, Hobart P, Stout R, Jones TR, Richie TL, Parker SE, Doolan DL, Norman J, Hoffman SL, Proc Natl Acad Sci USA 2001 98 10817 10822 10.1073/pnas.181123498 11526203
42. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. Currier JR, Kuta EG, Turk E, Earhart LB, Loomis-Price L, Janetzki S, Ferrari G, Birx DL, Cox JH, J Immunol Methods 2002 260 157 172 10.1016/S0022-1759(01)00535-X 11792386
43. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Sette A, Sidney J, del Guercio MF, Southwood S, Ruppert J, Dahlberg C, Grey HM, Kubo RT, Mol Immunol 1994 31 813 822 10.1016/0161-5890(94)90019-1 8047072
44. Definition of supertypes for HLA molecules using clustering of specificity matrices. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, Worning P, Sylvester-Hvid C, Lamberth K, Roder G, Justesen S, Buus S, Brunak S, Immunogenetics 2004 55 797 810 10.1007/s00251-004-0647-4 14963618
45. Unexpected fold in the circumsporozoite protein target of malaria vaccines. Doud MB, Koksal AC, Mi LZ, Song G, Lu C, Springer TA, Proc Natl Acad Sci USA 2012 109 20 7817 7822 10.1073/pnas.1205737109 22547819
46. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein. Calvo-Calle JM, Hammer J, Sinigaglia F, Clavijo P, Moya-Castro ZR, Nardin EH, J Immunol 1997 159 3 1362 1373 9233633
47. Common west African HLA antigens are associated with protection from severe malaria. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM, Nature 1991 352 6336 595 600 10.1038/352595a0 1865923
48. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M, Nucleic Acids Res 2008 36 Web Server issue 509 512 18463140
49. Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues. Vaughan K, Blythe M, Greenbaum J, Zhang Q, Peters B, Doolan DL, Sette A, Parasite Immunol 2009 31 2 78 97 10.1111/j.1365-3024.2008.01077.x 19149776
50. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL, J Exp Med 1993 178 1 27 47 10.1084/jem.178.1.27 8315383
51. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. Lin HH, Ray S, Tongchusak S, Reinherz EL, Brusic V, BMC Immunol 2008 9 8 10.1186/1471-2172-9-8 18366636
52. Several HLA alleles share overlapping peptide specificities. Sidney J, del Guercio MF, Southwood S, Engelhard VH, Appella E, Rammensee HG, Falk K, Rotzschke O, Takiguchi M, Kubo RT, et al. J Immunol 1995 154 1 247 259 7527812
53. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Sidney J, Grey HM, Southwood S, Celis E, Wentworth PA, del Guercio MF, Kubo RT, Chesnut RW, Sette A, Hum Immunol 1996 45 2 79 93 10.1016/0198-8859(95)00173-5 8882405
54. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. Sidney J, Southwood S, del Guercio MF, Grey HM, Chesnut RW, Kubo RT, Sette A, J Immunol 1996 157 8 3480 3490 8871647
55. A study of genetic diversity in the gene encoding the circumsporozoite protein (CSP) of Plasmodium falciparum from different transmission areas-XVI. Asembo Bay Cohort Project. Escalante AA, Grebert HM, Isea R, Goldman IF, Basco L, Magris M, Biswas S, Kariuki S, Lal AA, Mol Biochem Parasitol 2002 125 1-2 83 90 12467976
56. Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy. Zevering Y, Khamboonruang C, Good MF, Immunology 1998 94 3 445 454 10.1046/j.1365-2567. 1998.00514.x 9767430
57. Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial. Thera MA, Doumbo OK, Coulibaly D, Diallo DA, Kone AK, Guindo AB, Traore K, Dicko A, Sagara I, Sissoko MS, et al. PloS one 2008 3 1 1465 10.1371/journal.pone.0001465 18213374
58. Next generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite protein. Gandhi K, Thera MA, Coulibaly D, Traore K, Guindo AB, Doumbo OK, Takala-Harrison S, Plowe CV, Am J Trop Med Hyg 2012 86 5 775 781 10.4269/ajtmh.2012.11-0478 22556073
59. Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, Malawi. Bailey JA, Mvalo T, Aragam N, Weiser M, Congdon S, Kamwendo D, Martinson F, Hoffman I, Meshnick SR, Juliano JJ, J Infect Dis 2012 206 4 580 587 10.1093/infdis/jis329 22551816
60. CD8 T cell epitope distribution in viruses reveals patterns of protein biosynthesis. Diez-Rivero CM, Reche PA, PloS one 2012 7 8 43674 10.1371/journal.pone.0043674 22952734
61. Biology and immunology of sporozoite invasion of liver cells and exoerythrocytic development of malaria parasites. Hollingdale MR, Prog Allergy 1988 41 15 48 3043420
62. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Tenzer S, Wee E, Burgevin A, Stewart-Jones G, Friis L, Lamberth K, Chang CH, Harndahl M, Weimershaus M, Gerstoft J, et al. Nat Immunol 2009 10 6 636 646 10.1038/ni.1728 19412183